Stoke Therapeutics, Inc. STOK Service — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Stoke Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Stoke Therapeutics, Inc.’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s service — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s service — revenue?
- Stoke Therapeutics, Inc. (STOK) reported service — revenue of $1.15M in Q4 2025.
- How has Stoke Therapeutics, Inc.'s service — revenue changed year-over-year?
- Stoke Therapeutics, Inc.'s service — revenue decreased by 36.1% year-over-year, from $1.8M to $1.15M.
- What does service — revenue mean?
- This metric represents the total gross income generated specifically from service-based activities, such as research collaborations, consulting, or technical support arrangements. It reflects the company's ability to monetize its proprietary technology platform and scientific expertise beyond direct product sales. Monitoring this revenue stream provides insight into the diversification of the company's business model and its success in leveraging internal capabilities to generate non-dilutive capital.